slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 28,441-28,470
Pages 1,371
Rows per page 30
Component
28,441-28,470 of 41,127
14
The slide uses a consistent bar chart format to show growth trends across segments.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
Includes detailed footnotes regarding debt terms and equity instruments.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
10
The chart uses a back-to-back bar structure to visualize the distribution of disease control duration.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
11
The chart displays point estimates and 95% confidence intervals for the treatment effect across multiple clinical and demographic categories.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Loop · Mece Breakdown1 hit
13
The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
02
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
06
Includes a footer with acronym definitions.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
07
The slide uses a four-column layout to segment strategic focus areas (HER2-high, HR+, gBRCA, TNBC).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
09
The slide uses a horizontal timeline/process flow to map patient treatment stages against therapeutic interventions and resistance mechanisms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
14
Includes a risk table and summary statistics table (Median PFS, HR).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
17
The slide uses a mirrored bar chart to compare adverse event frequencies by grade, alongside a summary table of clinical safety outcomes.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
20
The diagram illustrates a randomized clinical trial flow.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
21
The slide presents clinical trial baseline data, likely for a breast cancer study given the markers (ER+, PgR+, ESR1m, CDK4/6i).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
23
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
25
The slide uses a split-panel design to compare two patient cohorts (ESR1m detectable vs not detectable).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
26
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
35
The slide uses a patient journey/treatment pathway framework to map current standard of care against emerging therapeutic interventions.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Confession1 hit
42
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
21
Uses a hub-and-spoke diagram to connect market segments to a central growth driver.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
24
The slide uses bar charts to show quality ratings and a bulleted list for social proof/awards.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
25
Uses a Good-Better-Best-Premium framework to organize product offerings.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
35
Contains detailed footnotes explaining adjustments for asset impairments, business transformation, and transaction costs.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
03
Azerion | Investor Day Presentation Deck | 48 slidesAzerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
04
Azerion | Investor Day Presentation Deck | 48 slidesAzerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
12
The slide uses a split-screen layout: historical performance on the left, strategic growth levers on the right.Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Business Model1 hit
38
Includes a disclaimer about accounting standards (Dutch GAAP vs IFRS).Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
02
Berkeley Lights | Mergers and Acquisitions Presentation Deck | 17 slidesBerkeley Lights | Mergers and Acquisitions Presentation Deck | 17 slides · Berkeley Lights
Conference presentation Investment bank 1 hit
01
Goldman Sachs | Investment Banking Pitch Book | 52 slidesGoldman Sachs | Investment Banking Pitch Book | 52 slides · Goldman Sachs
Consulting deck Investment bank Beat · Situation & Context1 hit